Low Density Lipoprotein Cholesterol

An antibody called "alirocumab" can significantly lower cholesterol levels in patients with an inherited disease associated with very high levels of low density lipoprotein cholesterol (LDL-C) or what is called "bad" cholesterol, new research has found.

According to a new study, an antibody called "alirocumab" can significantly lower cholesterol levels in patients with very high levels of low density lipoprotein cholesterol (LDL-C) or what is called "bad" cholesterol.

Vitamin C treatment has a possible role in benefiting patients with coronary heart disease (CHD) by countering the adverse effects of a high-fat meal. The serum triglyceride concentration is raised after a high-fat meal and this postprandial state (occurring after a meal) is critical in development of fat deposits in blood vessels. The infiltrati...

An antibody called "alirocumab" can significantly lower cholesterol levels in patients with an inherited disease associated with very high levels of low density lipoprotein cholesterol (LDL-C) or what is called "bad" cholesterol, new research has found.

According to a new study, an antibody called "alirocumab" can significantly lower cholesterol levels in patients with very high levels of low density lipoprotein cholesterol (LDL-C) or what is called "bad" cholesterol.

Vitamin C treatment has a possible role in benefiting patients with coronary heart disease (CHD) by countering the adverse effects of a high-fat meal. The serum triglyceride concentration is raised after a high-fat meal and this postprandial state (occurring after a meal) is critical in development of fat deposits in blood vessels. The infiltrati...